Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,395
datasets available to search
ShareScore release 0.7.1
Dataset results
1,395 results for “Tumor immunity”
VISTA immune-checkpoint blunts radiotherapy induced anti-tumor immune response
GEO Series GSE295914. Mus musculus. 8 samples. Type: Expression profiling by high throughput sequencing.
BRAF V600E in Pediatric Low-Grade Gliomas: Exploring the Tumor Microenvironment and Immune Cell Infiltration dynamics in vivo.
GEO Series GSE252367. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
Tractable mouse TNBC models capture the heterogeneous tumor immune microenvironment and adaptation to PD-L1 blockade
GEO Series GSE292146. Mus musculus. 38 samples. Type: Expression profiling by high throughput sequencing.
Autophagy Promotes Growth of High Tumor Mutational Burden Tumors by Inhibiting a T Cell Immune Response [RNA-seq]
GEO Series GSE154654. Mus musculus. 8 samples. Type: Expression profiling by high throughput sequencing.
MAIT cells regulate NK cell mediated tumor immunity (RNA-Seq)
GEO Series GSE179139. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing.
Potent anti-tumor immunity and reversal of CD8 T cell exhaustion by spatially and functionally targeting Treg cells in the tumor microenvironment
<p>1×10<sup>6</sup> of splenic GFP<sup>+</sup> Tregs were purified from WT (n=4) and KO mice (n=4) via FACS isolation. RNA was extracted using RNeasy Micro Kit (Qiagen) following its standard protocol and RNA degradation and contamination was monitored on 1% agarose gels. For RNA sequencing, libraries were prepared using NEBNext® Ultra TM RNA Library Prep Kit for Illumina® (NEB, USA) following manufacturer’s recommendations and index codes were added to attribute sequences to each sample. The clustering of the index-coded samples was performed on a cBot Cluster Generation System using PE Cluster Kit cBot-HS (Illumina) according to the manufacturer’s instructions. After cluster generation, the library preparations were sequenced on an Illumina platform and paired-end reads were generated. All samples were prepared at the same time and sequenced on the same lane. Original image data file from high-throughput sequencing platforms (like Illumina) is transformed to sequenced reads (called Raw Data or Raw Reads) by CASAVA base recognition (Base Calling). Raw data in FASTQ format were processed through fastp. In this step, clean data (clean reads) were obtained by removing reads containing adapter and poly-N sequences and reads with low quality from raw data. All the downstream analyses were based on the clean data with high quality. Reference mouse genome and gene model annotation files were downloaded from genome website browser (NCBI/UCSC/Ensembl). Paired-end clean reads were mapped against the reference genome using the Spliced Transcripts Alignment to a Reference (STAR) software. FeatureCounts was used to count the read numbers mapped of each gene. And then RPKM (Reads Per Kilobase of exon model per Million mapped reads) of each gene was calculated based on the length of the gene and reads count mapped to this gene. The FPKM gene expression matrix, R code, DEG list, and targeted gene list are uploaded in this project.</p>
Novel N6-methylandenosine-related long non-coding RNAs as a Prognostic Signature Associated with Tumor Immune Cell Infiltration in Breast Cancer
<p><strong>Supplementary Figure S1</strong>. The correlation between risk score and six types of tumor-infiltration immune cells in TIMER database.</p> <p><strong>Supplementary Figure S2</strong>. Expression levels of m6A-LPS related lncRNAs in 16 breast cancer tissues and paired normal breast tissues.</p>
A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
ClinicalTrials.gov study NCT03260322. IPD Sharing: NO. Countries: 9. Publications: 0.
Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)
ClinicalTrials.gov study NCT02978118. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations
ClinicalTrials.gov study NCT06279130. IPD Sharing: NO. Countries: 1. Publications: 0.
Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies
ClinicalTrials.gov study NCT01915992. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immune Modulatory DC Vaccine Against Brain Tumor
ClinicalTrials.gov study NCT03914768. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors
ClinicalTrials.gov study NCT05035706. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Plasma Tumor-promoting Factors and Immune Function After Laparotomy, Cytoreductive Surgery and HIPEC vs. PIPAC in Patients With Peritoneal Metastasis
ClinicalTrials.gov study NCT04122885. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
ClinicalTrials.gov study NCT03158064. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors
ClinicalTrials.gov study NCT06076135. IPD Sharing: NO. Countries: 1. Publications: 0.
Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma
ClinicalTrials.gov study NCT01456104. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gut Microbiota (GM) Biodiversity in Patients With Solid Tumors Treated With Immune Checkpoint Inhibitors (ICIs): a Monocenter Prospective Study to Identify the Interactions Between GM and ICIs
ClinicalTrials.gov study NCT07236983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors
ClinicalTrials.gov study NCT02747407. IPD Sharing: Not stated. Countries: 1. Publications: 0.
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
ClinicalTrials.gov study NCT06398418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.